title: [Argentine Consensus of Congenital Toxoplasmosis].
abstract: The mother-to-child transmission in Toxoplasma gondii infection occurs only when the infection is acquired for the first time during pregnancy. The prenatal and early postnatal diagnosis can only be achieved by serological testing. Serologic tests have different sensitivities, specificities and complexities, so that different tests in more than one blood sample are necessary for the diagnosis. Serological follow-up of the infants should be conducted during the first year of life or until the diagnosis of congenital toxoplasmosis can be ruled out. Treatment recommendations try to reduce the transmission rate and the risk of congenital damage. Congenital toxoplasmosis incidence rate is approximately 5 per 1000 births, but can be reduced to 0.5 per 1000 with an active screening program. The aim of this consensus group was to review the scientific literature on congenital toxoplasmosis and prepare a statement on prevention, diagnosis and treatment that should be implemented in our country.
authors.affiliation: Asociación Argentina de Zoonosis. rdurlach@hospitalaleman.com
authors.forename: Ricardo
authors.initials: R
authors.lastname: Durlach
authors.forename: Federico
authors.initials: F
authors.lastname: Kaufer
authors.forename: Liliana
authors.initials: L
authors.lastname: Carral
authors.forename: Cristina
authors.initials: C
authors.lastname: Freuler
authors.forename: Mariana
authors.initials: M
authors.lastname: Ceriotto
authors.forename: Marcelo
authors.initials: M
authors.lastname: Rodriguez
authors.forename: Hector
authors.initials: H
authors.lastname: Freilij
authors.forename: Jaime
authors.initials: J
authors.lastname: Altcheh
authors.forename: Liliana
authors.initials: L
authors.lastname: Vazquez
authors.forename: Rosana
authors.initials: R
authors.lastname: Corazza
authors.forename: Maria
authors.initials: M
authors.lastname: Dalla Fontana
authors.forename: Hector
authors.initials: H
authors.lastname: Arienti
authors.forename: Edgardo
authors.initials: E
authors.lastname: Sturba
authors.forename: Silvia
authors.initials: S
authors.lastname: Gonzalez Ayala
authors.forename: Emilio
authors.initials: E
authors.lastname: Cecchini
authors.forename: Cristina
authors.initials: C
authors.lastname: Salomon
authors.forename: Monica
authors.initials: M
authors.lastname: Nadal
authors.forename: Nestor
authors.initials: N
authors.lastname: Gutierrez
authors.forename: Eduardo
authors.initials: E
authors.lastname: Guarnera
mesh_terms: D000913:Antibodies, Protozoan / Q000097:blood; D001118:Argentina; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D008403:Mass Screening; D015997:Neonatal Screening; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D011296:Prenatal Diagnosis; D012307:Risk Factors; D014125:Toxoplasmosis, Congenital / Q000175:diagnosis / Q000628:therapy / Q000635:transmission
chemical_list: D000913:Antibodies, Protozoan